Podcasts about chief science officer

So, there are dire wolves living on Earth again. They were “de-extincted” by Colossal Biosciences. And today on the show their Chief Science Officer joins me to share her view on why the de-extinction matters — not as a science project, but because it will help solve problems that threaten every species on earth, including us. Beth Shapiro is the Chief Science Officer at Colossal Biosciences, and she helped to bring back the dire wolf or, as others call it, a gray wolf with 20 genetic edits. There is a fierce debate about what de-extinction even means, and we discuss that, but whatever you call them, there are now three big wolves living in an undisclosed location and they wouldn't be there if not for the DNA that Beth and her team edited. Colossal is also working to bring back the wooly mammoth, the Tasmanian tiger, the dodo and other animals that have long been extinct. Why? Listen to find out… Chapters:(01:19) - The Most Oprah Question Beth's Ever Been Asked (03:04) - Moonshots Require You to Create a Giant List of Problems (04:19) - The Things We'll Solve Along the Way, a la the Original Moonshot… to the Moon (05:57) - Beth's Journey: From Broadcast Journalism to Ancient DNA (09:13) - How a Sediment Core Solved a Mammoth Mystery (11:36) - Why Charismatic Animals Matter (a.k.a. Why Riz Is Everything) (12:38) - What's Up With Romulus, Remus, and Khaleesi? (14:19) - But Are They Really “Dire Wolves”? The Controversy Over 20 Genetic Edits (21:45) - Should We Do This? Beth's Ethics Framework for Builders (23:51) - Advice for Moonshot Builders (25:10) - Why We Want Dodos, Mammoths, and Thylacines Back Links & Resources:Colossal BiosciencesBeth ShapiroPopTech -- a conference I love!  Support Future Around & Find OutFollow Dan on LinkedInGet the free Future Around & Find Out newsletterBecome a paid subscriber and help future proof the podcast!Sponsor the show? Are you looking to reach an audience of senior technologists and decision-makers? Email me: dan@modernproductminds.com---Music by Jonathan Zalben

We find ourselves in environments like homes, offices, airports, even hospitals where invisible factors can shape everyday wellbeing. But how much does the air we breathe actually affect immune health? And are the filtration systems in our homes and public spaces truly doing what we think they are? In this episode, Natalie Tysdal sits down with Dr. Kathryn Worrilow, founder and Chief Science Officer of LifeAire Systems. With decades of research in clinical environments from IVF laboratories to senior living communities and acute-care hospitals, Dr. Worrilow shares what science has revealed about indoor air quality, airborne pathogens, and immune protection. This conversation is about awareness, not fear. Because you can't manage what you don't measure. You'll learn: • How invisible airborne pathogens, far beyond dust and allergens, can influence immune health • Why standard air filtration may capture particles but not eliminate them • The difference between purification technologies and why byproducts like ozone matter • What hospitals have learned about air quality and infection rates • Practical questions you can ask about the air in your home, office, school, or healthcare setting Midlife is often a season of reassessment of hormones, immunity, and resilience. Understanding the role air quality plays in overall wellness is one more layer of informed decision-making. This episode offers steady, research-backed insight to help you feel empowered in the spaces you live and work. episode webpage with more info: https://www.natalietysdal.com/post/indoor-air-quality-and-immune-health-what-women-in-midlife-need-to-know Natalie's website: https://www.natalietysdal.com Follow Natalie: Instagram: https://www.instagram.com/ntysdal TikTok: https://www.tiktok.com/@ntysdal Facebook: https://www.facebook.com/NatalieTysdal Listen now and subscribe for weekly conversations that help women make sense of midlife health—without hype, panic, or overwhelm. DISCLAIMER: Natalie Tysdal is a health journalist, not a licensed medical professional. This podcast is for informational purposes only and is not a substitute for medical advice, diagnosis, or treatment.

Evan Zhao is the Co-founder and CEO of Pacagen, using biotechnology to revolutionize consumer products. Before Pacagen, he served as Chief Science Officer at ODDITY, and previously built and sold Revela. He earned a PhD in Chemical Engineering from Princeton University, and completed work as a Schmidt Science Fellow at Harvard.See omnystudio.com/listener for privacy information.

Today, I'm delighted to welcome Dr. Yael Joffe, a leading expert in nutrigenomics who speaks internationally at conferences on translating the science of genetics into clinical practice. She holds a PhD in nutrigenomics from the University of Cape Town, where her research focused on the genetics of obesity. I met Yael earlier this fall and decided to invite her on the podcast to explore the growing field of lifestyle genetics. In our conversation today, we dive into the effects of nutrigenomics, nutrition genetics, and SNPs, which she refers to as spelling changes in our DNA. We cover genetic testing in the industry, red flags, DNA health, and her polygenic approach to weight loss resistance. We also discuss both perimenopause and menopause from the perspective of genetics and epigenetics, and the role of insulin signalling and glucose. Yael's insights are deeply informative. Her pioneering work on 36 metabolic pathways and her ability to make complex genetic information accessible and actionable make this a truly invaluable conversation. IN THIS EPISODE, YOU WILL LEARN: Women and gaining weight after starting HRT Neurotransmitters and what they reveal about mood, anxiety, and addiction tendencies Why do certain people break down dopamine and serotonin either too fast or too slowly? How touch and genuine connection can switch on feel-good genes Sunlight, weather, and environment affect genetic expression. What acupuncture and infrared therapies do at the gene level Why hormones are only part of the picture when addressing midlife weight gain How glucose regulation and insulin sensitivity shift through menopause Dr. Joffe's polygenic testing model connects multiple pathways rather than single genes How Yael's approach to genetic testing differs from that of others in the field Bio: YAEL JOFFE, PhD  Yael is globally recognized as a leading expert in nutrigenomics. In 2000, she was part of the team that built the first lifestyle genetics test, and since then has been responsible for creating many others. She is the author of four books: The Power of Genetics, It's Not Just Your Genes, Genes to Plate, and SNP Journal. Yael has been published in multiple peer-reviewed scientific journals, hosts the Power of Genetics podcast, and is a highly regarded speaker in genetics. Yael built the first online nutrigenomics platform for clinician education and has developed and supervised genomics courses around the world. She has trained thousands of healthcare practitioners globally, also teaching at Rutgers University and the Maryland University of Integrative Health. In 2018, Yael founded 3X4 Genetics and now serves as its Chief Science Officer.    Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Join other like-minded women in a supportive, nurturing community (The Midlife Pause/Cynthia Thurlow)  Cynthia's Menopause Gut Book is on presale now! Cynthia's Intermittent Fasting Transformation Book The Midlife Pause supplement line Connect with Dr. Yael Joffe 3X4 Genetics Instagram Facebook

Dr. Riley Kirk welcomes Dr. Harold Han, Chief Science Officer and Co-Founder of Vertosa to explore the fascinating world of the science powering modern cannabis beverages and infused products. Known in the industry as “The Happy Chemist,” Dr. Han explains how emulsion technology solves the classic oil-and-water problem that makes cannabinoids difficult to incorporate into drinks. The conversation breaks down how water-compatible cannabinoids are created, why droplet size and consistency matter for potency and onset, and how stability challenges differ between beverages and gummies. They explore oxidation rates of major cannabinoids, packaging risks like “scalping” from can liners, and new patented approaches to preserving potencyin infused drinks. They also examine the full beverage development pipeline, from cannabinoids and infusion technology to formulation, manufacturing, testing, and distribution, highlighting the many points where potency and quality can be affected. Dr. Han clarifies the difference between nano and micro emulsions, why most commercial cannabis drinks use nano systems, and how natural emulsifiers influence formulation choices. The discussion further explores how the human body processes emulsified cannabinoids, why food (especially fat) changes edible effects, and how fast-acting beverages work at a physiological level. They discuss new human research initiatives, patient applications such as consistent dosing without sugar or smoke, and how standardized emulsions could transform both clinical research and at-home use. Looking ahead, Dr. Han shares insights on full-plant formulations, the future of cannabis as a precise delivery system for medicine, and the role of science-driven innovation in making cannabinoids more accessible, consistent, and scalable across recreational, wellness, and medical markets. Chapters 00:00 Welcome + Meet Dr. Harold Hahn (“Happy Chemist”) & What Vert Does 00:52 From Cannabis Stigma to Conscious Living: Harold's Personal Journey 02:18 The Oil-and-Water Problem: Emulsifiers Explained for Cannabis Drinks 04:13 Vert's Water-Compatible Cannabinoids: Droplet Size, Consistency & Effects 09:48 Stability Deep Dive: Physical Separation, Oxidation Rates & Gummies vs Beverages 16:05 Packaging Pitfalls: Can Liners, “Scalping,” FTIR Testing & a New Patent Fix 22:49 Beverage R&D Checklist: The 7-Step Supply Chain + Taste/Mouthfeel Priorities 27:16 Flavor Wars: Tasteless THC vs “Tastes Like the Plant” 28:37 Nano vs Micro Emulsions Explained (It's Not Just Size) 31:40 Why Most Cannabis Drinks Use Nano: Natural Emulsifiers & Custom Control 34:38 Fast-Acting vs Slow-Acting: What Your Gut Does With Emulsions 37:41 Food Effects + The New UCSF Cannabis Beverage PK Lab 40:32 Patient Benefits: Consistent Dosing, No Sugar, Full-Plant Medicine 44:23 Research, DIY Possibilities & Big-Picture Wrap-Up   Connect with Dr. Harold Han LinkedIn: Harold Han Ph.D. (The Happy Chemist) Company: Vertosa — https://vertosa.com/   Want Exclusive Content and Ad-Free Episodes? Join the Bioactive Patreon community for as little as $1/month to ask guests your burning questions, access exclusive content, and connect with Dr. Kirk one-on-one. www.Patreon.com/Cannabichem

In this episode, Peter Swartz, Co-Founder and Chief Science Officer at Altana, reveals how the company's AI-powered supply chain knowledge graph has helped stop hundreds of millions of dollars in forced labor goods from crossing borders and contributed to some of the largest counter-narcotics seizures in investigators' careers. Peter shares the real-world impact Altana is making across both the public and private sectors.Peter breaks down how Altana's multi-tier supply chain visibility works to trace forced labor cotton through global networks, how dual-use chemicals are being diverted into fentanyl production, and how the platform helps governments and enterprises collaborate to avoid billions of dollars in trade disruptions while saving hundreds of millions in tariff fees.Key Topics Covered- How Altana blocked hundreds of millions of dollars in forced labor goods at U.S. borders- The role of AI knowledge graphs in mapping multi-tier global supply chains- How Altana supports CBP enforcement of the Uyghur Forced Labor Prevention Act- Product passports and how they expedite legitimate goods through customs- The difference between forced labor entering legit supply chains vs. legit goods entering illicit ones- How logistics companies use Altana to prevent their networks from being misused- Proactive vs. reactive approaches to supply chain risk using probabilistic AI models- Scenario modeling for geopolitical disruptions including Taiwan and global conflicts- Saving billions in supply chain disruptions and hundreds of millions in tariff feesEpisode Timestamps00:00 - Introduction and overview of Altana's real-world impact00:41 - Understanding forced labor as a multi-tier supply chain problem03:09 - Hundreds of millions in forced labor goods stopped at borders03:45 - How the AI knowledge graph maps global supply chain connections04:15 - Working with CBP on the Uyghur Forced Labor Prevention Act04:35 - Product passports and expediting goods through customs04:51 - Counter-narcotics and the dual-use chemical problem05:45 - Helping logistics companies stop network misuse06:27 - From alert to action and the system handoff process06:49 - Responsible AI and the role of human-in-the-loop decisions07:33 - Proactive vs. reactive supply chain intelligence08:08 - Scenario modeling for geopolitical disruptions and resiliencyAbout Peter SwartzPeter Swartz is Co-Founder and Chief Science Officer at Altana. He has spoken on global trade, supply chains, and machine learning at the World Trade Organization, the World Customs Organization, the U.S. Court of International Trade, and the National Academies of Medicine. Previously, Peter was Head of Data Science at Panjiva, listed as one of Fast Company's most innovative data science companies in 2018 and later acquired by S&P Global. He holds patents in machine learning and global trade, and completed his education at Yale, MIT, and EPFL.About AltanaAltana is the world's first Value Chain Management System, providing AI-powered supply chain intelligence to governments, enterprises, and logistics providers. The platform is built on a proprietary knowledge graph comprising more than 2.8 billion shipments, tracking over 500 million companies and 850 million facilities globally. Altana covers more than 50% of global trade, making it the most comprehensive and accurate supply chain map available.Resources Mentioned- Altana Atlas platform and AI knowledge graph- U.S. Customs and Border Protection (CBP)- Uyghur Forced Labor Prevention Act (UFLPA)- Product passports for cross-border compliance- Altana's disruption and tariff scenario modeling toolsPeter's Socials:LinkedIn — https://www.linkedin.com/in/pgswartz/Partner LinksBook Enterprise Training — https://www.upscaile.com/

This week on Tech Radio, we're asking if the era of the "infinite scroll" is finally over. As Ireland joins a wave of European nations introducing a digital age of majority, we look at the "bellwether" legal case in Los Angeles that is taking Mark Zuckerberg to task. Is it time to stop blaming the content and start blaming the design?We also celebrate a major Irish energy milestone: the launch of the country's first grid-scale battery storage system in Edenderry. Plus, we discuss why Apple's upcoming "budget" MacBook feels out of character, why your headphones might be "toxic," and the security firm warning us all to stop letting AI generate our passwords.Our guest this week is Dr Ryne Sherman, Chief Science Officer at Hogan Assessments. He joins Niall to discuss the psychology of the 2026 workplace, the rise of "quiet cracking," and why—despite the AI revolution—the core qualities of a great leader haven't changed since the days of Plato.—----- Listen to Tech Radio now on Apple, Spotify and YouTube.Apple - https://podcasts.apple.com/us/podcast/tech-radio-ireland/id256279328Spotify - https://open.spotify.com/show/5vAWM1vvHbQKYE79dgCGY2YouTube - https://www.youtube.com/@TechRadioIrelandRSS - https://feeds.transistor.fm/techradio

Dr. Olivier de Hon is the Chief Science Officer and Director of Intelligence and Investigations at Doping Authority Netherlands. In this episode, he shares more about the history of the organization, progress in estimating doping prevalence, challenges in assessing the effectiveness of anti-doping programs, and considerations for promoting clean sport among elite athletes as well as recreational athletes in gyms and fitness centers.

In this episode, we sit down with Dr. Rachele Pojednic, a Stanford faculty member and Chief Science Officer at Restore Hyper Wellness, to talk about the confusing gray zone between wellness fads and real science. We get into why so many health trends (like saunas, cold plunges, supplements, red light therapy, and IV drips) feel like they work… even when the research hasn't caught up yet. Rachele breaks down how wellness companies and influencers often take small, weak studies and turn them into massive claims — and how to spot that as a consumer. We also talk about what actually looks promising in the research right now (yes, creatine comes up), and why “natural” doesn't automatically mean “safe” or “effective.” If you've ever wondered what's legit, what's hype, and what's just expensive placebo, this episode will make you feel so much smarter.Sign up for our newsletter here!For weekly episodes, come join the Foodie Fam!Check out our book!Chat with us on IG @foodweneedtotalk!Be friends with Juna on Instagram and Tiktok! Learn about your ad choices: dovetail.prx.org/ad-choices

This episode is an interview with Dr. Wouter Vaes, the Chief Science Officer of Peregrion. We discuss how accelerator mass spectrometry is being used in early clinical development for drug metabolism and pharmacokinetics. We discuss using this technology to support development of oncology agents, determining absolute bioavailability without IV toxicology work, and more. Links discussed in the show:You can contact Wouter by email: wouter.vaes@peregrion.com Connect with Peregrion on LinkedIn or their websiteSymposium on microtracer studies FDA guidance on safety testing of drug metabolitesWhite paper on human ADME data You can connect with Nathan on LinkedIn and send me a message Send Nathan a message Sign up for Nathan's newsletter Copyright Teuscher Solutions LLCAll Rights Reserved

In this follow-up conversation, Dr. Lorne Brown sits down again with Dr. Mark Ratner, Chief Scientific Officer at Theralogix, to revisit the controversy surrounding resveratrol and IVF outcomes.After a 2019 study suggested resveratrol might reduce implantation rates, Dr. Ratner conducted a deep dive into the latest research — including four newer prospective randomized trials and a recent study on pterostilbene.The result? A very different picture.This episode breaks down what the science actually says about egg quality, implantation, miscarriage risk, and live birth outcomes — and whether resveratrol truly poses a risk during IVF.Key Takeaways:The 2019 resveratrol study was retrospective and had significant baseline differences between groups.Four newer prospective randomized trials show no reduction in pregnancy rates with resveratrol.Multiple studies report improvements in egg quality, embryo quality, and fertilization rates.SIRT1 plays a central role in ovarian reserve and uterine receptivity.Pterostilbene, a better-absorbed analog, restored implantation and live birth rates in aging mice.Dr. Mark Ratner's Bio:Dr. Ratner is a board-certified urologist and the Chief Science Officer of Theralogix, a Washington, DC based company which markets micronutrient supplements with a focus on reproductive health. Dr. Ratner did his undergraduate and graduate studies in nutrition at Cornell University. He received his M.D. and residency training at Tulane University School of Medicine.Where to find Dr. Mark Ratner:Website: https://theralogix.com/Special Offer: https://theralogix.com/discount/LORNE?redirect=/products/ovanad Ian Kent - VP, Sales & Business Development

​​Join our champion program: mark@themomentumcompany.comAttend a Thriving Leader event: https://thriving-leader-2026.lovable.app/Instagram: @the.momentum.companyLinkedIn: /momentum-companyIn this episode of The Intentional Agribusiness Leader, Mark sits down with Landon Bunderson, Chief Science Officer at Nano Yield, for a thoughtful conversation about intentional leadership, organizational clarity, and how innovation actually works inside a growing agribusiness.Landon leads both science and marketing at Nano Yield—a combination that forces constant clarity. His definition of intentionality is simple but demanding: say fewer things, repeat them often, and never lose sight of why the company exists. At Nano Yield, everything ladders up to one goal—making the sales team's job easier by ensuring customers clearly understand the value of the people and the products.One of the central themes of the episode is the power of repetition in leadership. Landon explains that effective leaders don't constantly reinvent their message. Instead, they identify the few things that matter most and put them on repeat. Just like a political stump speech, clarity is built through consistency—not novelty. Leaders don't need more ideas; they need sharper focus.The conversation also explores what Nano Yield actually does and why “nanotechnology” doesn't need to be scary. Landon breaks down nano-scale delivery in simple terms, explaining how their technology improves the efficiency of fertilizers and crop inputs by helping nutrients reach plant cells more effectively. The result is better performance, less waste, and improved outcomes for growers.From there, the discussion shifts to culture and growth. Having been with Nano Yield for over a decade, Landon shares how culture has evolved as the company has scaled. He describes culture through a family analogy—clear expectations, consistent communication, defined boundaries, and increasing autonomy over time. When people know what's expected and feel trusted, they thrive.Mark and Landon dive into the realities of hiring and growth, including one of the hardest leadership challenges: realizing when someone is in the wrong role. Landon frames these moments not as failures, but as necessary course corrections—helping people move on to roles where they can truly succeed.Another key insight from the episode is the idea that people don't actually thrive in total freedom—they thrive within clear boundaries. As companies grow, systems and processes become essential not to restrict people, but to support them. Structure creates stability, and stability enables innovation.The episode closes with a discussion on creativity and problem-solving. Landon recommends the book Big Magic by Elizabeth Gilbert, emphasizing that creativity isn't about reinventing everything—it's about approaching challenges with curiosity and courage. That creative muscle, when paired with disciplined execution, becomes a powerful leadership advantage.This conversation is a reminder that intentional leadership isn't loud or flashy. It's focused, repeatable, human, and deeply practical.Listen if you are:A leader trying to create clarity in a fast-growing organizationBalancing innovation with executionStruggling with focus, messaging, or alignment across teamsBuilding culture while scaling people, systems, and productsCurious about how technology and leadership actually intersect in ag

NAD⁺ has become a popular topic in fertility and longevity conversations, often surrounded by bold claims and supplement hype. But what does the science actually say—and how does NAD⁺ truly relate to egg quality, ovarian health, and reproductive aging?In this episode, I speak with Dr. Mark Ratner to explore the real role of NAD⁺ in mitochondrial function, cellular energy production, and DNA repair in egg cells. We discuss why NAD⁺ levels decline with age, how inflammation and metabolic stress accelerate that decline, and what current research actually supports when it comes to supplementation. This conversation moves beyond quick fixes, offering an evidence-informed perspective for both people trying to conceive and practitioners seeking clarity amid the noise.Key Takeaways:NAD⁺ is essential for cellular energy production and DNA repair in egg cellsFertility decline with age reflects reduced cellular function, not only egg countChronic inflammation and metabolic stress accelerate NAD⁺ depletionRaising NAD⁺ levels does not automatically restore cellular healthEffective fertility support requires lifestyle, metabolic, and inflammatory care—not supplements aloneDr. Mark Ratner's Bio:Dr. Ratner is a board-certified urologist and the Chief Science Officer of Theralogix, a Washington, DC based company which markets micronutrient supplements with a focus on reproductive health. Dr. Ratner did his undergraduate and graduate studies in nutrition at Cornell University. He received his M.D. and residency training at Tulane University School of Medicine.Where to find Dr. Mark Ratner:Website: https://theralogix.com/Special Offer: https://theralogix.com/discount/LORNE?redirect=/products/ovanad Ian Kent - VP, Sales & Business Development

MOPs & MOEs is powered by TrainHeroic, the best coaching app on the planet. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Click here to get 14 days FREE and a consult with the coaches at TrainHeroic to help you get your coaching business rolling on TrainHeroic. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ MOPs & MOEs delivers our training through ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TrainHeroic and you can ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠get your first 7 days of training with us FREE by clicking here.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠To continue the conversation, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠join our Discord!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ We have experts standing by to answer your questions.You asked for it, here it is: a peptides episode. These are the hotness lately, getting tons of business and media attention (and anecdotal reports from athletes). But we constantly hear that there is no human safety or effectiveness data. So what are well intentioned consumers to do? To answer that question we have Dr. Rachele Pojednic back on the pod, and she is uniquely suited to talk about this issue. Rachele is a renowned expert, researcher, international speaker and thought-leader in nutrition and exercise science. Her primary roles are Adjunct Lecturer at Stanford University and Chief Science Officer at RestoreLabs. We don't just look at the current science on peptides, we also dive into what structural challenges have prevented more research in this area. As it turns out, we may be in a moment where regulatory changes may create some big opportunities in the very near future.Rachele mentioned examine.com as a great resource for analysis and summaries on nutrition and supplement research.We also touched on a recent article in Task & Purpose where a Marine Corps lawyer claimed his client unknowingly took prohibited peptides thinking they were approved supplements.

Why do so many people feel unwell even when their labs are labeled "normal"? Are we using laboratory testing as a guide, or are we letting numbers drive decisions without enough context? In this episode, I sit down with Dr. Ralph Esposito, a board-certified nutritionist, functional medicine practitioner, and expert in metabolic health, to unpack one of the most misunderstood tools in modern medicine: laboratory testing. As Dr. Esposito explains, labs are a cornerstone of healthcare, but they are also among the most frequently misused. We explore how nutrition and metabolic labs should be evaluated responsibly by prioritizing clinical context, pre-test probability, biological variability, and individual response rather than relying on isolated or outdated reference ranges. Our conversation also dives into common misunderstandings around testosterone replacement therapy, cardiovascular risk, and why population-based "normal" values often miss what is happening in the individual. Dr. Esposito introduces an N of 1 framework, reframing labs not as definitive answers but as decision-support tools meant to guide truly personalized care. If you want a clearer, more thoughtful way to interpret labs and assess real health risk, this episode will change how you look at your numbers.   Key takeaways: Lab Interpretation Caution: Misinterpretation of lab results can lead to incorrect health assessments; patient history and context are crucial in lab result analysis. Individualized Guidelines: Dr. Esposito advocates for a shift from population-based to personalized markers of health for more accurate patient care. Role of Testosterone in Health: While TRT can be beneficial, it should be considered carefully, weighing potential health benefits against side effects like elevated hematocrit and hemoglobin levels. Lifestyle Modifications: Recognize the impact of lifestyle changes in conjunction with medical treatments for long-term health improvements. Precision Medicine Vision: The future of healthcare lies in the integration of AI and individualized patient data to tailor precise medical interventions effectively.   More About Dr. Ralph Esposito:   Dr. Ralph Esposito is a licensed naturopathic physician and acupuncturist specializing in precision preventive and integrative medicine. He serves as Chief Science Officer at AG1 where he oversees scientific strategy and clinical research and is an adjunct professor at New York University. His work focuses on evidence-based N-of-1 approaches to risk reduction metabolic health and longevity translating complex science into clinically meaningful outcomes.   Website Instagram Connect with me! Website Instagram Facebook YouTube

Peptides have taken the health and wellness space by storm. Is it hype, or do they have significant health outcomes? Jim LaValle, a pioneer in the world of peptides, is here to break down why they're the future of medicine and how they can help you live a healthier, longer life. Jim has dedicated over 40 years to the science of health and wellness. As an expert in integrative and precision medicine, he has been at the forefront of peptide therapy for 15 years. He's seen firsthand how peptides can help people regain their vitality, whether recovering from an injury, battling hormonal imbalances, or even combating metabolic disorders.  In this episode, Jim and I explore the fascinating world of peptides and how they're being used to enhance everything from weight loss to improved sleep. You'll discover which peptides you should consider, how they work in your body, and why they're the next frontier in preventive healthcare.  "The advantage of peptides is that they're signaling molecules that our bodies are already familiar with. So it's a gentler way of correcting problems that you may have."  ~ Jim LaValle In This Episode: - Meet Jim LaValle - History and basics of peptides - Finding the right peptides and providers - Popular peptides and their benefits - The best peptides for overall wellbeing - Future of peptides and potential side effects - MIORA: Personalized peptides & lifestyle programs - Jim La Valle's daily routine for optimal health - Episode wrap-up and Jim's message to the world About Jim LaValle: Jim LaValle, RPh, CCN, is a clinical pharmacist, board-certified nutritionist, and author with 40+ years of experience. He specializes in precision and performance health, integrating metabolic-based care. Founder of Metabolic Code Enterprises, he has taught at institutions like the University of Cincinnati and George Washington School of Medicine. LaValle has worked with elite sports teams, the military, and first responders to optimize their performance and recovery. He has authored 26 books, including Cracking the Metabolic Code, and over 200 articles. Currently, he serves as Chief Science Officer at Life Time, leading scientific initiatives for its longevity and performance program, MIORA. Instagram: https://www.instagram.com/therealjimlavalle/   Facebook: https://www.facebook.com/people/Jim-LaValle/100062990514032/   Website: https://www.jimlavalle.com/  Where to find me: IG: https://www.instagram.com/jen_gottlieb/    TikTok: https://www.tiktok.com/@jen_gottlieb     Facebook: https://www.facebook.com/Jenleahgottlieb    Website: https://jengottlieb.com/    My business: https://www.superconnectormedia.com/     YouTube: https://www.youtube.com/@jen_gottlieb

What does the future of crop science look like? Bayer's top R&D leaders share how FieldView™ and innovation pipelines are driving ag forward in 2026. In this episode, Tom Eickhoff, Chief Science Officer for Climate, and Mike Graham, Head of Plant Breeding at Bayer Crop Science, join Tom and Andy to reflect on 2025 and preview what's ahead in 2026. From the evolution of FieldView™ to Bayer's investments in genome editing, data science, and innovation pipelines, they explore how digital integration and plant breeding are rapidly advancing. Learn how new tools, trialing strategies, and customer-focused development are reshaping the way Bayer delivers value to growers. Plus, hear advice for staying informed and curious as agriculture evolves.

The backlash against Dr. Peter Attia has been swift and unforgiving since newly released documents from the Jeffrey Epstein files revealed an extensive and friendly correspondence between the celebrity longevity doctor and the convicted sex offender — including over 1,700 mentions of Attia in the trove — complete with casual and crude exchanges that reflected an ongoing relationship well after Epstein's 2008 conviction. Attia's name popping up repeatedly in the federal materials has shocked many of his followers and critics alike, not least because he built his public brand on health, integrity, and longevity advice while quietly maintaining a social rapport with someone now widely understood as a deeply exploitative predator. One especially unsettling detail — emails joking about sex and lifestyle — has made even the most technical defense of his interactions ring hollow for critics who see this not as harmless professional contact but as an elitist embrace of a man whose abuses were known to the world.The blowback hasn't been abstract — it's already cost Attia real-world roles and credibility. He resigned from his position as Chief Science Officer at David Protein and has been forced to apologize publicly, calling the emails “embarrassing, tasteless, and indefensible,” while CBS News reportedly weighs cutting ties with him as a contributor amid internal and public pressure to dissociate from his tarnished judgment. Many observers have labeled his apology as insufficiently contrite and criticized him for not addressing the deeper ethical implications of befriending a convicted child trafficker, arguing that his reputation as a trusted health authority is fundamentally shaken. Rather than confronting how his willingness to hobnob with Epstein reflects on his values and professional integrity, Attia's defensive framing — insisting he wasn't involved in criminal activity and emphasizing that he wouldn't act that way “today” — has been seen by some as tone-deaf and self-protective, feeding into narratives about elites dodging accountability.to contact me:bobbycapucci@protonmail.comsource:Dr. Peter Attia, longevity expert, apologizes for "indefensible" emails to Jeffrey Epstein - CBS News

The backlash against Dr. Peter Attia has been swift and unforgiving since newly released documents from the Jeffrey Epstein files revealed an extensive and friendly correspondence between the celebrity longevity doctor and the convicted sex offender — including over 1,700 mentions of Attia in the trove — complete with casual and crude exchanges that reflected an ongoing relationship well after Epstein's 2008 conviction. Attia's name popping up repeatedly in the federal materials has shocked many of his followers and critics alike, not least because he built his public brand on health, integrity, and longevity advice while quietly maintaining a social rapport with someone now widely understood as a deeply exploitative predator. One especially unsettling detail — emails joking about sex and lifestyle — has made even the most technical defense of his interactions ring hollow for critics who see this not as harmless professional contact but as an elitist embrace of a man whose abuses were known to the world.The blowback hasn't been abstract — it's already cost Attia real-world roles and credibility. He resigned from his position as Chief Science Officer at David Protein and has been forced to apologize publicly, calling the emails “embarrassing, tasteless, and indefensible,” while CBS News reportedly weighs cutting ties with him as a contributor amid internal and public pressure to dissociate from his tarnished judgment. Many observers have labeled his apology as insufficiently contrite and criticized him for not addressing the deeper ethical implications of befriending a convicted child trafficker, arguing that his reputation as a trusted health authority is fundamentally shaken. Rather than confronting how his willingness to hobnob with Epstein reflects on his values and professional integrity, Attia's defensive framing — insisting he wasn't involved in criminal activity and emphasizing that he wouldn't act that way “today” — has been seen by some as tone-deaf and self-protective, feeding into narratives about elites dodging accountability.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-moscow-murders-and-more--5852883/support.

The backlash against Dr. Peter Attia has been swift and unforgiving since newly released documents from the Jeffrey Epstein files revealed an extensive and friendly correspondence between the celebrity longevity doctor and the convicted sex offender — including over 1,700 mentions of Attia in the trove — complete with casual and crude exchanges that reflected an ongoing relationship well after Epstein's 2008 conviction. Attia's name popping up repeatedly in the federal materials has shocked many of his followers and critics alike, not least because he built his public brand on health, integrity, and longevity advice while quietly maintaining a social rapport with someone now widely understood as a deeply exploitative predator. One especially unsettling detail — emails joking about sex and lifestyle — has made even the most technical defense of his interactions ring hollow for critics who see this not as harmless professional contact but as an elitist embrace of a man whose abuses were known to the world.The blowback hasn't been abstract — it's already cost Attia real-world roles and credibility. He resigned from his position as Chief Science Officer at David Protein and has been forced to apologize publicly, calling the emails “embarrassing, tasteless, and indefensible,” while CBS News reportedly weighs cutting ties with him as a contributor amid internal and public pressure to dissociate from his tarnished judgment. Many observers have labeled his apology as insufficiently contrite and criticized him for not addressing the deeper ethical implications of befriending a convicted child trafficker, arguing that his reputation as a trusted health authority is fundamentally shaken. Rather than confronting how his willingness to hobnob with Epstein reflects on his values and professional integrity, Attia's defensive framing — insisting he wasn't involved in criminal activity and emphasizing that he wouldn't act that way “today” — has been seen by some as tone-deaf and self-protective, feeding into narratives about elites dodging accountability.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-epstein-chronicles--5003294/support.

Send us a textThis month, we sat down with Jessica Starcevich – a passionate entomologist and Chief Science Officer at Spalding Labs – to discuss Integrated Pest Management (IPM) and biological fly control methods for sheep and goats. Jessica provides details about effective fly control methods for ruminant operations' unique needs. She also dives into the science behind Fly Predators - beneficial insects that kill flies before they hatch - and provides resources to understand which fly control methods will be most effective for your farm's unique needs.Learn more about biological fly control and Spalding Labs Fly Predators here: https://info.spalding-labs.com

Corrosion rarely announces itself as a "big water problem." It shows up as leaching at the tap, residual loss in the field, premature equipment replacement, and the slow, expensive erosion of decision-quality.  Pat Rosenstiel (CEO) and Wolf Merker (chemist/Chief Science Officer) of Great Water Tech lay out a system-wide view of corrosion control—starting with what changed in Flint from a technical standpoint and moving into why many utilities still struggle to meet expectations when standards and risk assumptions shift.  System-wide corrosion control starts with chemistry and consequences  A source-water change can shift corrosivity fast. If corrosion control does not adjust proactively, the downstream effects show in metal release and public exposure. Wolf stresses the distinction between the technical problem and the political challenges, then points to corrosion control as a solvable technical matter when it is treated as a system condition—not a single asset issue.  Why "phosphate-only" isn't the end of the story  Trace frames what most operators recognize: many municipalities use phosphate inhibitors to form a tenacious film and reduce corrosion. Wolf argues phosphates are "a little bit of old news" in practice and explains the approach Great Water Tech discusses with their German partners—using phosphates and silicates together in the right amounts to create a tighter separation between water and metal.  Barriers, biology, and the disinfection tradeoff  Wolf breaks corrosion drivers into three sources: chemical, biological, and electrochemical (dissimilar metal corrosion). He also ties corrosion to cascading operational decisions—especially disinfectant strategy. If residual loss pushes a system from chlorine to chloramine, Wolf warns that corrosivity can increase dramatically, and that corrosion can amplify the formation of disinfection byproducts as chlorine reacts with what is in the water.  What industrial water treaters should listen for  Pat connects the same barrier logic to industrial priorities—CapEx, OpEx, and lifecycle extension in closed systems (cooling towers, closed chilled loops, boilers). Wolf clarifies that closed systems require different product "flavors," while keeping the core concept consistent: the combined silicate/phosphate approach remains the best path he is aware of.  Listen to the full conversation above. Explore related episodes below. Stay engaged, keep learning, and continue scaling up your knowledge!    Timestamps    02:20 - Trace sets the tone for the episode: decision-quality improves when you "rethink the way that you think you know things," especially around tests and procedures   08:20 - Words of Water with James McDonald  11:00 - Upcoming Events for Water Treatment Professionals   18:22 - Interview with Pat Rosenstiel, CEO of Great Water Tech & Wolf Merker, Chief Science Officer of Great Water Tech  23:00 - Flint technical breakdown  27:30 - Corrosion control options  32:20 - Scale vs. Corrosion   43:40 – Algae Control Pivot    Connect with Pat Rosenstiel  Website: Great Water Tech | Water Treatment Solutions  LinkedIn: https://www.linkedin.com/in/pat-rosenstiel-a148952/   Great Water Tech LLC: Overview | LinkedIn     Connect with Wolf Merker  Website: Great Water Tech | Water Treatment Solutions  LinkedIn: https://www.linkedin.com/in/wolf-merker-a1b95284/    Great Water Tech LLC: Overview | LinkedIn    Guest Resources Mentioned   NSF/ANSI/CAN 60 — Drinking Water Treatment Chemicals: Health Effect   NSF — Drinking Water Treatment Chemicals Certification (NSF/ANSI/CAN 60) (how certification works)   ANSI Webstore listing (official standard access/purchase)  EPA — Lead and Copper Rule (regulation hub)  EPA — Lead and Copper Rule Improvements (LCRI) (final rule page)  EPA fact sheet — Tap Monitoring Requirements (LCRI) (sampling protocol changes)  Great Water Tech  Folmar (Great Water Tech) — corrosion inhibitor (phosphate + silicate blend)  Algae Armor (Great Water Tech) — nutrient-binding tool for ponds/lakes  EPA Distribution System Toolbox — Pigging fact sheet (PDF) (removing biofilm/scale/sediment from mains)  U.S. Bureau of Reclamation report page (chlorine vs chloramine impacts incl. corrosion/leaching discussion)  AWWA Opflow article (main cleaning techniques incl. pigging): AWWA's utility-facing perspective on cleaning options  Silicate corrosion inhibitors  Historical context for silicate–phosphate combinations    Scaling UP! H2O Resources Mentioned  AWT (Association of Water Technologies)   AWT Technical Training (March 2026)  Scaling UP! H2O Academy video courses  Submit a Show Idea  The Rising Tide Mastermind  Ep 422 Inside the Association of Water Technologies with John Caloritis Hach Water Analysis Handbook      Words of Water with James McDonald Today's definition is the smallest functional unit of a cooling tower that contains its own heat exchange section, fan or air-moving system, water distribution system, and drift eliminators.    2026 Events for Water Professionals  Check out our Scaling UP! H2O Events Calendar where we've listed every event Water Treaters should be aware of by clicking HERE.   

In this episode of the All Things Sustainable podcast, we explore the geopolitical and macroeconomic issues impacting sustainability, energy and climate strategies in 2026.   We speak to Carlos Pascual, Senior Vice President and Head of Geopolitics and International Affairs at S&P Global Energy and a former US Ambassador to Mexico and Ukraine.  Carlos describes a fragmented geopolitical landscape marked by significant uncertainty about the direction of global climate policy, action and finance — leaving progress largely in the hands of the private sector.  "We have huge changes ahead and look for the private sector to have to play a much more central role in the overall momentum on clean technology and investments in renewable energy," Carlos says.  We speak to S&P Global Ratings Global Chief Economist Paul Gruenwald to understand the macroeconomic factors influencing sustainability. Paul says AI is the dominant story for 2026.   "We're seeing great numbers out of data center and AI-related investment, but almost everything else is flat," Paul tells us.  To understand the outlook for climate change and the growing importance of adaptation alongside mitigation efforts, we speak to Dr. Terence Thompson, Chief Science Officer at the S&P Global Climate Center of Excellence. He explains how advances in climate science are helping to better understand the probability of climate hazards.   "Getting at that probability is really key to making those kinds of very practical decisions about how do we allocate limited resources to cope with climate change and adapt to it," Terence says.   And to understand the outlook for the energy transition, we speak to Roman Kramarchuk, Head of Integrated Narratives and Policy Analytics at S&P Global Energy. Roman explains how the world is balancing growing energy demands with sustainability priorities in an increasingly fractured global landscape.  "There's a big regional story here, and this is a regional story that plays out both in the technology, in the supply chains, and in the geopolitical side," Roman says.  Read S&P Global's Top 10 Sustainability Trends to Watch in 2026 | S&P Global Read The Copper Conundrum: Why Meeting AI-Era Electrification Demands Is a Race Against Time Listen to a replay of the Jan. 29 webinar: Sustainability Nexus: S&P Global's Top 10 Sustainability Trends to Watch in 2026 This piece was published by S&P Global Sustainable1 and not by S&P Global Ratings, which is a separately managed division of S&P Global.  Copyright ©2026 by S&P Global  DISCLAIMER       By accessing this Podcast, I acknowledge that S&P GLOBAL makes no warranty, guarantee, or representation as to the accuracy or sufficiency of the information featured in this Podcast. The information, opinions, and recommendations presented in this Podcast are for general information only and any reliance on the information provided in this Podcast is done at your own risk.         Any unauthorized use, facilitation or encouragement of a third party's unauthorized use (including without limitation copy, distribution, transmission or modification, use as part of generative artificial intelligence or for training any artificial intelligence models) of this Podcast or any related information is not permitted without S&P Global's prior consent subject to appropriate licensing and shall be deemed an infringement, violation, breach or contravention of the rights of S&P Global or any applicable third-party (including any copyright, trademark, patent, rights of privacy or publicity or any other proprietary rights).    This Podcast should not be considered professional advice. Unless specifically stated otherwise, S&P GLOBAL does not endorse, approve, recommend, or certify any information, product, process, service, or organization presented or mentioned in this Podcast, and information from this Podcast should not be referenced in any way to imply such approval or endorsement. The third party materials or content of any third party site referenced in this Podcast do not necessarily reflect the opinions, standards or policies of S&P GLOBAL. S&P GLOBAL assumes no responsibility or liability for the accuracy or completeness of the content contained in third party materials or on third party sites referenced in this Podcast or the compliance with applicable laws of such materials and/or links referenced herein. Moreover, S&P GLOBAL makes no warranty that this Podcast, or the server that makes it available, is free of viruses, worms, or other elements or codes that manifest contaminating or destructive properties.       S&P GLOBAL EXPRESSLY DISCLAIMS ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR OTHER DAMAGES ARISING OUT OF ANY INDIVIDUAL'S USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE, THIS PODCAST OR THE INFORMATION PRESENTED IN THIS PODCAST. 

Aging does NOT have to keep us down. In this episode, join me for a feel-good conversation with the CSO of Berkeley Life– Cathy Eason– all about midlife, hormones, and protecting your heart as you age stronger.  Together, we explore how boosting mitochondrial health and blood flow can radically improve energy, resilience, and overall vitality.  Kathy shares actionable lifestyle strategies to increase nitric oxide production for easing symptoms, plus offers supportive solutions when you need a little extra help during perimenopause and menopause.  We also talk about targeted supplements that support heart health, circulation, mood, sleep, stress response, and neurotransmitters—all in one place.  Tune in here to boost your blood flow, help your heart, and thrive through midlife and beyond!Cathy Eason Cathy Eason is the Chief Science Officer at Berkeley Life. She has over 20 years of experience as a functional medicine focused nutritionist, women's health educator, speaker, and wellness strategist specializing in midlife health. She bridges cutting-edge science with practical solutions for perimenopause and menopause, focusing on cardiovascular health, nitric oxide biochemistry, and whole-body resilience. Cathy's known for translating complex physiology into empowering insights that help women thrive through midlife and beyond. IN THIS EPISODE Cathy's perimenopause journey & her non-negotiables for thriving through it  The benefits of regulating your nervous system How insulin resistance impacts perimenopause symptoms  Why we need to talk more about blood flow for whole body wellness  The benefit of nitric oxide in perimenopause and menopause  How to best support yourself through midlife hormone shifts  The positive impact of Berkeley Life supplementation  How to get 15% off your Berkeley Life Nitric Oxide supplement!  QUOTES“We're seeing those perimenopausal signs come on earlier and earlier, and unfortunately, I think it's happening to younger and younger women too.” “We need to stop apologizing for what's happening to us. Recognize that we can be proactive about our health, but we also don't have to apologize for sweating during a meeting, or being a little cranky in the morning because we didn't get good sleep the night before.” “That's the biggest thing I feel by taking the Berkeley Life supplementation— I have consistent energy every day and I wake up motivated for the day ahead of me. And to me that equates to being energized, to having mitochondrial energy to get me through the day.” RESOURCES MENTIONED Order my new book: The Perimenopause Revolution https://peri-revolution.com/ Order your Berkeley Life Nitric Oxide Support Supplement HERE! https://berkeleylife.pxf.io/Vxvdja Use Code: THRIVE15 for 15% off! Berkeley Life Website Berkeley Life on Instagram Berkeley Life on Facebook Berkeley Life LinkedIn Berkeley Life on YouTube RELATED EPISODES  675: Feeling Off After 40? The Surprising Vitality Molecule to Reignite Your Energy, Libido & Confidence with Cathy Eason 711: Estrogen, Inflammation, and Your Heart Health: What Every Woman Needs to Know with Dr. Sanjay Bhojraj 704: Hormone Intelligence for Women in Midlife: How to Thrive Through Perimenopause with Dr. Aviva Romm 693: Tired All the Time? It Might Be Hidden Problems With Your Mitochondria with Siobhan Mitchell

Send us a textIn this episode of the WTR Small-Cap Spotlight, host Tim Gerdeman and healthcare analyst Robert Sassoon are joined by Dr. Jim Gilligan, President and Chief Science Officer of Entropy Neurodynamics (ASX: ENP), formerly Tryptamine Therapeutics. Dr. Gilligan explains the motivation behind the company's rebrand and its decision to prioritize three core therapeutic targets: Binge Eating Disorder, Fibromyalgia, and Irritable Bowel Syndrome/abdominal pain. Although Entropy has reported positive Phase 2a results using oral psilocybin across these indications, Dr. Gilligan outlines why the company is shifting its strategy toward developing proprietary IV‑delivered psilocin formulations combined with psychotherapy, beginning with binge eating disorder. The discussion also covers Entropy's work on real‑time EEG and brain entropy as a potential biomarker, the company's financing,  regulatory roadmap, and longer‑term expansion opportunities in areas such as PTSD.

In this groundbreaking episode of Pushing the Limits, we sit down with Christian Drapeau, MSc - stem cell scientist, author of Cracking the Stem Cell Code, and founder & Chief Science Officer of the regenerative health company Stemregen. Christian shares his 25-plus years of pioneering research into stem cells and regenerative biology, beginning with his revolutionary idea that stem cells are the body's innate repair system, not just a medical oddity studied in labs. What We Discuss in This Episode The History of Stem Cell Science: How Christian's early neurophysiology work led him to explore blue-green algae (Aphanizomenon flos-aquae) and its surprising effects on immune health.  Early hypotheses and lab studies that showed certain natural compounds actually increase circulating stem cells, kick-starting the idea of Endogenous Stem Cell Mobilization (ESCM). The Quest for Natural Stem Cell Mobilisers: Christian's global travels to find powerful plant medicines used in traditional cultures, from Madagascar's Aloe macroclada to sea buckthorn from the Tibetan plateau, and how these botanicals can increase stem cell circulation by as much as 80%. Stemregen Science & Products: We unpack Christian's work validating that increasing your own stem cells in circulation can support tissue repair, healthy aging, and whole-body regeneration, hitting at the heart of why so many chronic conditions persist. What the Stemregen Protocol includes: STEMREGEN Release — designed to support your body's natural release and migration of stem cells.  Stemregen Mobilise — supports stem cell delivery by improving microcirculation and capillary health. Stemregen Signal — enhances cellular communication so stem cells can navigate to where they're needed most. Incredible Cases & Stories: Christian highlights compelling real-world cases showing how enhancing stem cell circulation supports recovery, improved vitality, and quality of life, not by treating symptoms, but by strengthening the body's own repair system. Stem Cell Therapies: Pros & Cons We also dive into conventional stem cell therapies (umbilical, adult stem cells, exosomes), contrasting them with the natural approach Christian advocates, including safety, effectiveness, and longevity implications. Why We Age: A New Perspective Christian previews his upcoming book on aging - reframing aging as a balance between repair vs. regeneration speed, and what practical lifestyle and botanical strategies can help tip the scales towards regeneration.  

In this episode of SleepTech Talk, we're joined by Aubrey Sawyer, President and Co-Founder, and Michelle Alencar, PhD, Chief Science Officer and Co-Founder of inHealth and CoachLinq, to discuss how developing better habits—especially in the new year—can transform sleep outcomes and improve adherence to PAP therapy.We dive into why PAP adherence is one of the biggest challenges in sleep medicine, and how coaching, behavior science, and data-driven approaches can help patients stick to therapy, maintain motivation, and achieve long-term success.Whether you're a sleep clinician, DME/HME professional, or someone personally using PAP therapy, this conversation offers practical insights into:Why patients struggle with PAP complianceHow habit formation impacts sleep and exerciseThe role of coaching in long-term adherenceUsing behavioral science to drive sustainable health outcomesHow sleep technology can support—not replace—human behavior change

World leaders in Davos are talking about 'tech sovereignty', but can Europe or the UK really achieve digital autonomy when so much of the AI and cloud infrastructure is controlled by a handful of US firms? Danny and Katie talk to Hany Farid about the geopolitics of tech, and the fear of an 'AI kill switch' - is this scaremongering or a real concern?Guest: Hany Farid, UC Berkeley professor and Co‑Founder & Chief Science Officer at GetReal Security.Image: Getty Hosted on Acast. See acast.com/privacy for more information.

Ben Backus, Chief Science Officer, and James Blaha, CEO and Founder of Vivid Vision, discuss their work addressing binocular dysfunctions and improving visual field testing. Their innovative visual test uses a consumer-grade VR headset to deliver a gamified, less stressful, more engaging experience for patients, encouraging longer, more frequent testing. This approach also improves dataset precision and overcomes barriers in clinical trials for new therapeutics for diseases such as glaucoma and macular degeneration, potentially accelerating the development of vision-saving treatments. Ben explains, "Vivid Vision addresses two conditions. One of them is binocular dysfunctions, which include conditions like amblyopia, strabismus, and convergence insufficiency. And the other one that we're really focusing strongly on now is visual field testing, which is especially important to use for monitoring people who have glaucoma. It also gets used for screening tests for glaucoma, and it's an especially important part of getting new therapeutics approved for any medication that is going to try to preserve your sight. That includes macular degeneration, a particular flavor of macular degeneration, degeneration called geographic atrophy, inherited retinal diseases, diabetic retinopathy, and stroke. It's the visual field test that we are putting the majority of our effort into, but we still also treat binocular dysfunction."   James elaborates, "I originally got started, I guess, because I grew up with some binocular vision disorders. I had a lazy eye and a crossed eye, also known as strabismus and amblyopia. And I had kind of the traditional experience as a kid where I was not cooperative with the treatments, wearing my eye patch, and doing eye exercises, and that sort of thing. And I wasn't successfully treated as a kid. About 60% of the time, that's the case in the US, where kids are not successfully treated for conditions. Then, when I was older, in my mid-twenties, I got interested in this topic through a TED talk by a neuroscientist, Sue Barry. That ultimately caused me to make the first prototypes, and I was able to gain 3D vision depth perception from some of those first prototypes. And that's ultimately what caused us to start the company." #VividVision #VRHealthcare #EyeHealth #MedicalTechnology #DigitalHealth #VisionTesting #Innovation #Glaucoma #MacularDegeneration #Amblyopia #HealthTech #VirtualReality #PatientCare #EarlyDetection #ClinicalTrials seevividly.com Download the transcript here

Ben Backus, Chief Science Officer, and James Blaha, CEO and Founder of Vivid Vision, discuss their work addressing binocular dysfunctions and improving visual field testing. Their innovative visual test uses a consumer-grade VR headset to deliver a gamified, less stressful, more engaging experience for patients, encouraging longer, more frequent testing. This approach also improves dataset precision and overcomes barriers in clinical trials for new therapeutics for diseases such as glaucoma and macular degeneration, potentially accelerating the development of vision-saving treatments. Ben explains, "Vivid Vision addresses two conditions. One of them is binocular dysfunctions, which include conditions like amblyopia, strabismus, and convergence insufficiency. And the other one that we're really focusing strongly on now is visual field testing, which is especially important to use for monitoring people who have glaucoma. It also gets used for screening tests for glaucoma, and it's an especially important part of getting new therapeutics approved for any medication that is going to try to preserve your sight. That includes macular degeneration, a particular flavor of macular degeneration, degeneration called geographic atrophy, inherited retinal diseases, diabetic retinopathy, and stroke. It's the visual field test that we are putting the majority of our effort into, but we still also treat binocular dysfunction."   James elaborates, "I originally got started, I guess, because I grew up with some binocular vision disorders. I had a lazy eye and a crossed eye, also known as strabismus and amblyopia. And I had kind of the traditional experience as a kid where I was not cooperative with the treatments, wearing my eye patch, and doing eye exercises, and that sort of thing. And I wasn't successfully treated as a kid. About 60% of the time, that's the case in the US, where kids are not successfully treated for conditions. Then, when I was older, in my mid-twenties, I got interested in this topic through a TED talk by a neuroscientist, Sue Barry. That ultimately caused me to make the first prototypes, and I was able to gain 3D vision depth perception from some of those first prototypes. And that's ultimately what caused us to start the company." #VividVision #VRHealthcare #EyeHealth #MedicalTechnology #DigitalHealth #VisionTesting #Innovation #Glaucoma #MacularDegeneration #Amblyopia #HealthTech #VirtualReality #PatientCare #EarlyDetection #ClinicalTrials seevividly.com Listen to the podcast here

Welcome back, sweet friend, to Season 7 of The Cannabis Truth Podcast—your trusted source for medical marijuana education, plant therapy wisdom, and cannabinoid science made simple.

Welcome back for Season 6 of Redefiners! What better way to kick off the new year than introducing Russell Reynolds Associates' first-ever Chief Science Officer, Tomas Chamorro-Premuzic. And if that wasn't enough, Emma Combe from the Leadership Lounge joins Marla Oates for this special conversation. In this episode, Tomas shares his latest research on talent management, leadership development, and the human-AI interface. He'll explain why authenticity is overrated, how to use negative thinking as a positive force, and what leaders new in their roles can do to gain competence and confidence to be successful. He'll dig into AI and how people can stand out in a sea of technology while avoiding the growing problem of “AI workslop.” He'll look at how AI is impacting the traditional career ladder and what leaders need to do to develop young talent for future leadership roles. And he'll highlight the key leadership topics he's tracking in 2026. We'll also hear from Amy Scissons, RRA's Chief Marketing and Communications Officer, who will highlight a key AI challenge many leaders are only just beginning to notice.  Four things you'll learn from this episode: How to rethink authenticity and use negative thinking as a positive force What leaders new to their roles need to do to gain competence and be successful How to avoid AI workslop and how AI is impacting the traditional career ladder What are the key leadership topics Tomas is tracking in 2026 If you enjoyed this episode, you might also like these Redefiners episodes: The Leadership Lessons That Shaped Us: Celebrating 100 Episodes of Redefiners Leadership Lounge: How to Create and Maintain Impact as a Leader Banking on AI: How Goldman Sachs CIO Marco Argenti Is Rewriting the AI Playbook Leadership Lounge: Unleashing AI's potential: Are you ready to lead the charge? Talking Transformational Leadership with RRA's CEO Constantine Alexandrakis Leadership Lounge: How to nail your first year as CEO

In this episode of SuperPsyched, Dr. Adam Dorsay sits down with Dr. Ben Rein, an acclaimed neuroscientist and Chief Science Officer at the Mind Science Foundation. They discuss Dr. Rein's book 'Why Brains Need Friends' and the critical importance of social connections for mental and physical health. The conversation dives into the science of empathy, the impact of loneliness and social isolation, and practical tips for building and maintaining meaningful relationships. They also explore interesting analogies, such as comparing social interactions to the care of plants and the concept of a diverse social diet. Listeners are encouraged to rethink their social habits and embrace the benefits of real human connections.00:00 Welcome to SuperPsyched with Dr. Adam Dorsay00:28 The Importance of Friendship and Social Connection01:11 Introducing Dr. Ben Rein and His Book01:35 The Neuroscience of Connection08:35 Defining Loneliness, Isolation, and Solitude17:53 Tips for Combatting Loneliness33:43 The Power of Empathy36:17 Conclusion and Final ThoughtsHelpful Links:Dr. Ben Rein WebsiteDr. Ben Rein LinkedInDr. Ben Rein TikTokWhy Brains Need Friends-The Neuroscience of Social Connection Book

In this episode of The Impostor Syndrome Files, we talk about why authenticity is overrated and what to do instead. My guest this week is Dr. Tomas Chamorro-Premuzic, psychologist, professor, Chief Science Officer at Russell Reynolds Associates and author of the new book Don't Be Yourself. Tomas argues that it's not raw authenticity that makes you a good leader. Great leaders care deeply about what others think of them. They leverage their emotional intelligence and engage in strategic impression management, which leads them to come across as more authentic and trustworthy to others. Tomas believes that instead of bringing our authentic selves to work, we should focus on being our best selves.We also explore concepts from Tomas' book Why Do So Many Incompetent Men Become Leaders (And How to Fix It), including a look at how we overvalue confidence and undervalue competence. We examine what DEI got wrong, how gender bias holds women back, and how AI can help us create more meritocratic systems. About My GuestTomas Chamorro-Premuzic is the Science Officer at Russell Reynolds Associates, a professor of business psychology at University College London and at Columbia University, a cofounder of Deeper Signals, and an associate at Harvard's Entrepreneurial Finance Lab. He is the author of several books, including Why Do So Many Incompetent Men Become Leaders? (and How to Fix It), upon which his popular TEDx talk was based, and I, Human: AI, Automation, and the Quest to Reclaim What Makes Us Unique.~Connect with Tomas:Website: https://drtomas.com/Book: https://www.amazon.com/Dont-Be-Yourself-Authenticity-Overrated/dp/1647829836  (or if you have a preferred bookseller - bookshop, Barnes & Noble)~Connect with Kim and The Impostor Syndrome Files:Join the free Impostor Syndrome Challenge:https://www.kimmeninger.com/challengeLearn more about the Leading Humans discussion group:https://www.kimmeninger.com/leadinghumansgroupJoin the Slack channel to learn from, connect with and support other professionals: https://forms.gle/Ts4Vg4Nx4HDnTVUC6Join the Facebook group:https://www.facebook.com/groups/leadinghumansSchedule time to speak with Kim Meninger directly about your questions/challenges: https://bookme.name/ExecCareer/strategy-sessionConnect on LinkedIn:https://www.linkedin.com/in/kimmeninger/Website:https://kimmeninger.com

Hi Parents! Adolescence is often framed as something parents must survive, but what if the teen years are one of the most powerful developmental opportunities of a lifetime? In this episode, I'm joined by renowned child development expert Ellen Galinsky to reframe how we understand adolescence and what teens truly need from the adults in their lives. Ellen Galinsky is President of the Families and Work Institute, former Chief Science Officer at the Bezos Family Foundation, and the author of The Breakthrough Years, one of the most highly praised parenting books of 2024. Drawing from decades of research and direct conversations with young people ages nine through nineteen, Ellen explains why teens don't want to pull away from parents but instead seek a different kind of relationship rooted in collaboration, respect, and trust. In our conversation, we explore what executive function skills really are and why adolescence is such a critical window for developing them. Ellen shares how parents can nurture these skills without controlling or rescuing, and how everyday conflict can be transformed into shared problem-solving using her Shared Solutions framework. We also talk about anxiety, pressure, and distraction in today's world, and why positive risk-taking plays such an important role in building competence, confidence, and resilience. This episode is especially meaningful for parents who feel overwhelmed by their teen's emotions, behaviour, or motivation and are searching for guidance that feels hopeful, science-backed, and practical. Ellen brings a deeply compassionate and empowering perspective that challenges common myths about teens and invites parents to see adolescence not as a crisis to endure, but as a breakthrough season for connection and growth. If you're parenting a tween or teen, supporting an anxious child, or wanting a stronger, healthier relationship with your adolescent, this conversation will leave you with a renewed sense of clarity, possibility, and confidence in what truly helps teens thrive. Big hugs, Monica Crnogorac Next Steps Book a Free Discovery Call Visit My Website for More Information on My 8-Week Program Connect With Me on Instagram

Happy New Year! This time of the year, most declare their resolutions - a huge majority including diet and weight loss, but what is the best way to do it?In this episode, our Chief Science Officer, Dr. Krista Kostroman, N.D., is joined by Ashley Koff, R.D., the founder of The Better Nutrition Program (BNP), the nutrition course director for UC Irvine's Susan Samueli Integrative Health Institute's Integrative and Functional Medicine Fellowship, and a faculty member at the Integrative and Functional Nutrition Academy (IFNA), where she teaches “An Integrative and Functional Nutrition Approach to Obesity and Weight Management.”She is also the author of the recently released book Your Best Shot (HarperOne, Jan. 6, 2026). With over 25 years of practice, Ashley leads a transformative movement in personalized nutrition — turning “better, not perfect” choices into practical, sustainable strategies that create meaningful health outcomes. Through patient stories and personal experience, she demonstrates that optimal health isn't just possible — it's essential to living a full life.Her work has been recognized widely: she was named one of CNN's Top 100 Health Makers, featured in InStyle as “Hollywood's Leading Dietitian,” and selected as Westin's Global Nutrition Ambassador.Join us today as we uncover the science and truth about weight health and nutrition! This includes the following highlights:What our genetics says about our weight, diet, and nutritionWhat GLP-1s arePersonalized Nutrition and how to create sustainable strategies for optimal health and weight lossHow supplements affect our diet and nutritionAshley Koff's book, “Your Best Shot”If you wish to learn more from Dr. Emily Splichal and Naboso, you may do so through the following channels:Website: https://thebetternutritionprogram.com/about/Instagram: @thebetternutritionprogramCheck out Ashley's book at: Your Best Shot: The Personalized System for Optimal Weight Heath - GLP-1 Shot or Not (Harper One, January 6, 2026). Out now wherever books are soldThe real revolution of the GLP-1 shots is the insight that the body regulates appetite and more with the hormones GLP-1, GIP, PYY, and CCK—and with Your Best Shot in hand, you can learn to optimize their function and your weight health for life______________________________________________________Keep yourself up to date on The DNA Talks Podcast! Follow our socials below:The DNA Talks Podcast Instagram: @dnatalkspodcastThe DNA Company Instagram: @thednacoThe DNA Company's Official Tiktok Account: @thednaco3______________________________________________________Medical Disclaimer: The information provided in this communication is for general informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here. If you think you may have a medical emergency, call your doctor or 911 immediately.

Episode 59: The Cherry on Top of Decades of Fusion Development   Brandon Sorbom, Chief Science Officer and Co-founder of Commonwealth Fusion Systems, is helping spend $3+ billion to turn hydrogen into abundant, safe and readily available energy. In our fourth fusion episode, Brandon educates us on the most time-tested approach to fusion which uses powerful magnets. CFS hopes to deliver commercial energy by the early 2030s.  0:00 Introduction  02:33 The Journey from MIT to Commonwealth Fusion Systems  04:30 Securing Funding and Building Credibility  05:44 Understanding Fusion and Tokamaks  08:44 Brandon’s Personal Journey to Fusion  12:34 Explaining the Tokamak and Fusion Process  28:23 Neutrons and Energy Conversion  31:39 High Temperature Superconducting Material  39:26 Scaling Up Production and Cost Considerations  42:53 The SPARC Prototype and Its Challenges  48:23 Transitioning from Spark to ARC  01:04:59 Conclusion and Final Thoughts 

Quantum computers usually mean massive machines, cryogenic temperatures, and isolated data centers. But what if quantum computing could run at room temperature, fit inside a server rack — or even a satellite?In this episode of TechFirst, host John Koetsier sits down with Marcus Doherty, Chief Science Officer of Quantum Brilliance, to explore how diamond-based quantum computers work — and why they could unlock scalable, edge-deployed quantum systems.Marcus explains how nitrogen-vacancy (NV) centers in diamond act like atomic-scale qubits, enabling long coherence times without extreme cooling. We dive into quantum sensing, quantum machine learning, and why diamond fabrication — including the world's first commercial quantum diamond foundry — could be the key to manufacturing quantum hardware at scale.You'll also hear how diamond quantum systems are already being deployed in data centers, how they could operate in vehicles and satellites, and what the realistic roadmap looks like for logical qubits and real-world impact over the next decade.Topics include: • Why diamonds are uniquely suited for quantum computing • How NV centers work at room temperature • Quantum sensing vs. quantum computing • Manufacturing challenges and timelines • Quantum computing at the edge (satellites, vehicles, sensors) • The future of hybrid classical-quantum systems⸻

Dr. Christina Rahm has worked as a medical, clinical, and research scientist in the pharmaceutical, nutraceutical, and biotechnology industries for Janssen, Johnson & Johnson, Biogen Idec/Biogen, UCB, Bristol Meyers Squibb, and Alexion. Additionally, she worked on the corporate side for Pfizer, Biogen, and Janssen and is currently the Chairman of International Science Nutrition Society and Chief Science Officer for ROOT Wellness. Dr. Rahm has also served as a formulator for several companies and manufacturing labs, including her own. She has created multiple provisional patents, proprietary formulas, and trade secrets in addition to authoring her first book, Cure the Causes: Live the Life you Want, Not the One Prescribed. Through years of laboratory research and ethical observations, she has developed a personalized and predictive consulting company working on everything from the environment to DNA and detox wellness plans in which Dr. Rahm helps clients reset their bodies and minds to be spiritually, mentally, emotionally, and physically balanced.

Read the full show notes here: https://www.draimee.org/boosting-egg-quality-what-we-know-about-nad-and-fertility-with-dr-mark-ratner In this top performing episode of 2025, I'm honored to be joined by Dr. Mark Ratner, Chief Science Officer at Theralogix. We're diving deep into the science of NAD+ - what it is, why it matters for fertility, and how it might help improve egg quality and outcomes for those pursuing IVF or egg freezing. Dr. Ratner, a board certified urologist, brings a wealth of expertise in nutritional supplements and reproductive health, and I've been looking forward to sharing this conversation with you. Throughout our interview, we explore the fascinating roles of NAD+ and sirtuins in ovarian health, discuss the latest research (from mice to humans!), and break down what these findings could mean for anyone hoping to preserve or boost their fertility. We also touch on practical strategies, from supplements to lifestyle changes, and address common questions about safety, effectiveness, and the future of this exciting area of reproductive science. In this episode, we cover: What NAD+ is and why it's crucial for egg health and fertility The role of sirtuins as "master regulators" in our cells and their connection to ovarian reserve How age-related declines in NAD+ and sirtuins impact egg quality Insights from animal and human studies on NAD+ supplementation and fertility outcomes The difference between NAD+ supplements and precursors like nicotinamide riboside Dietary and lifestyle approaches to boosting NAD+ (and why caloric restriction isn't for everyone) The growing awareness among fertility specialists and what's next for research in this field Resources Get OvaNAD+ from Theralogix at their website (use the code EGG for a 15% discount) Join The IVF Class Find Dr. Aimee's Fertility Essentials & Supplements   Do you have questions about IVF?Click here to join Dr. Aimee for The IVF Class. The next live class call is on Monday, January 12, 2025 at 4pm PST, where Dr. Aimee will explain IVF and there will be time to ask her your questions live on Zoom.   Dr. Aimee Eyvazzadeh is one of America's most well known fertility doctors. Her success rate at baby-making is what gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease your time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org. Other ways to connect with Dr. Aimee and The Egg Whisperer Show: Subscribe to my YouTube channel for more fertility tips!Subscribe to the newsletter to get updates

We are currently living in an epidemic of a sedentary lifestyle. As we live through our screens whether it be glued to our phones, tablets, or laptops, we tend to miss out on the benefits of movement in our day to day lives - how does movement benefit us?In this episode, Dr. Krista Kostroman, Chief Science Officer of the DNA Company, is joined by Dr. Emily Splichal. She is a functional podiatrist and human movement specialist, is the mind behind Naboso. With a spirit to challenge conformity, Dr. Splichal has taken her conventional Podiatric Medical degree and combined it with years of experience and expertise in human movement and sensory science to found Naboso.Dr. Splichal believes that our experience in this world is built around sensory stimulation and our ability to process, perceive, and integrate this information effectively. Since 2012, Dr. Splichal has been traveling the world to share her unique approach to human movement, foot function, and barefoot science. Having taught in 35 countries and to over 25,000 professionals, Dr. Splichal has quickly become a sought out leader in barefoot training and rehabilitation. Here are the highlights of today's episode:03:59 How Our Body Feeds Into Mental Experiences08:59 How People Can Shift Through Movement and Fascial Engagement15:17 Walking as An Access Point to Health26:04 How Fascia and Movement Informs Our Genetic Expression40:16 Supporting Fascia and Microvasculature46:33 Reintegrating Body with Space51:43 ConclusionIf you wish to learn more from Dr. Emily Splichal and Naboso, you may do so through the following channels:Website: https://www.naboso.com/Instagram: https://www.instagram.com/naboso_technology/YouTube: Master Movement with Naboso______________________________________________________Keep yourself up to date on The DNA Talks Podcast! Follow our socials below:The DNA Talks Podcast Instagram: @dnatalkspodcastThe DNA Company Instagram: @thednacoThe DNA Company's Official Tiktok Account: @thednaco3______________________________________________________Medical Disclaimer: The information provided in this communication is for general informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read here. If you think you may have a medical emergency, call your doctor or 911 immediately.

SEC Announces It Will Not Respond to Most No-Action Requests for Rule 14a-8 Shareholder Proposals.Government shutdown - the staff claimed they COULDN'T respond because after the shutdown, they had too much other work to do: “current resource and timing considerations following the lengthy government shutdown and the large volume of registration statements and other filings requiring prompt staff attention.” It just happens to coincide with Atkins saying there shouldn't be shareholder proposals, that's just a coincidence.John Cheveddan and Jim McRitchie - let's be honest, if it weren't for Cheveddan and McRitchie over 3 decades, we'd have less shareholder rights, and companies would not be such big whiners about “woke” shareholder proposals. Guys, you ruined it for all of us with your attention to democracy.Woke ESG shareholders like As You Sow, Arjuna, Trillium, and nuns - if we're honest, the nuns and SRI crowd might have been the straw, right? I mean they're putting in proposals that MAKE Exxon sue them! How dare they ask for carbon scope 3 emissions data!Antiwoke shareholders like NCPPR and Jesus - excluding Cheveddan/McRitchie, the highest volume of shareholder proposals have actually been the ANTI-woke filers, asking for things like a report on how companies will stop funding trans conversions (or one actual one where they asked about the reputational risk of NOT supporting un-trans-ing). Some of the proposals are so comically stupid, but the companies have to respond using third party lawyers and do the whole thing - maybe National Legal whatever center for whatever is the REAL straw?ISS and Glass Lewis - this was like 90% of what they did, since they certainly didn't suggest voting against any directors unless an activist was involved. So when Ramaswamy and Musk and DeSantis and Texas declared proxy advisors woke activists, it was hard to deny since they didn't do any work to vote out directors - just offer customers whatever voting pablum they wantedBlackRock and investors who never voted anywayOther - Atkins and Manhattan institute - lobbyists, administrationPepsi to cut product offering nearly 20% in deal with $4 billion activist ElliottPepsiCo said it also plans to accelerate the introduction of new offerings with simpler and more functional ingredients, including Doritos Protein and Simply NKD Cheetos and Doritos, which contain no artificial flavors or colors. The company also recently introduced a prebiotic version of its signature cola..WHO DO YOU BLAME?Pepsi CEO Ramon Laguarta - CEO since 2018, 21% influence, 43% connected to the board (so they're basically all known entities), has overseen basically zero shareholder value increase in the last 5 years, overall .513 TSR batting average - what has he been doing? Did he put a sign on the door begging an activist to come hang?Activist Elliott Management - Paul Singer is notorious as a real foodie… wait, no, sorry, he's known as a “vulture capitalist” who helped oust Jack Dorsey from Twitter because he didn't want him to hang in Africa, but was happy to have Elon Musk (who has five jobs) take it over. In 2021, he did take a 3% stake in Ahold Delhaize, a grocery store owner, so he's probably had a protein shake sprinkled on Doritos before?Pepsi's board - first of all, it's 14 people, which is like 7 people too many. Second - 4 finance types? Two pharma/med types? There are more people who know medicine than food - only ONE agribusiness repped on the board (Bunge) with the only other food production from Pepsi or ex-Pepsi execs? There are three directors on the nom committee with 10+ years on the board, and the other two have.. 9 years. Vasella has been there 23 years - time for some turnover.Roberto P. Martínez (International Chief Commercial Officer and CEO of New Revenue Streams) and Tara Glasgow (Executive Vice President and Chief Science Officer) - someone needs to be held responsible for Doritos Protein and Simply NKD CheetosJimmy Kimmel signs ABC extension through 2027Most of Kimmel's recent renewals have been multiyear extensions. There was no immediate word on whose choice it was to extend his current contract by one year.WHO DO YOU BLAME?Bob Iger - he yanked Kimmel to kiss Brendan Carr's ass and the affiliates, then put him back on when subscribers cancelled, then convinced affiliates to re-air, all because Kimmel said conservatives really didn't want Kirk's killer to be conservative? Now Kimmel is EXTENDED? It has to be the dumbest series of events since “Don't Say Gay” bill in Chapek's era, right?Disney's board - these are well known directors in the bag for Iger, and Iger would not even be CEO again if not for them. Susan Arnold, who at the time had more influence on the board than Iger, was chair of the nominating committee, had Mel Lagomasino and Derica Rice on with her, all went with Iger's hand picked choice of Bob Chapek. Arnold left the board, but both Rice and Lagomasino stayed behind to help choose… Bob Iger to return? Then brought on James Gorman, who hand picked HIS successor, to lead succession with Bob Iger again? Is anyone doing a job on this board? ISS - when Nelson Peltz took his Ike Perlmutter borrowed stake in Disney in 2024, ISS sided with Peltz and suggested voting out Mel Lagamasino because she was the longest tenured director and “responsible” for Disney's failed succession. In 2025, after Peltz lost and no one cared, ISS backed Lagamasino. With analysis like that, it's no wonder Disney can bow to the Trump Administration since there's no way ISS will actually suggest changing the board unless an old racist takes a stake.Brendan Carr - is this just a finger in the eye of Carr, the FCC, and the angry conservative affiliates by Iger? Is this Disney's way of being woke now?Other - Baby Doll Dixon, Jimmy Kimmel's agent - should have gotten him a 10 year deal with a player option out. Optically way better, gets bought out if they fire him.Trump says Netflix, WBD deal could be 'problem' as son-in-law Kushner backs Paramount bid“I'll be involved in that decision too,” Trump said days after Netflix agreed to buy WBD's film studiosParamount revealed in a regulatory filing that its hostile bid for WBD bid is being backed by Trump's son-in-law, Jared Kushner, who is a former White House advisor - and every Middle Eastern sovereign fund, as well as over $40bn by Larry Ellison (and David Ellison committed to spend more in a text to co-CEO Ted SarandosWHO DO YOU BLAME?Larry Ellison - without daddy's $40bn (and more - what's $40bn when you have $269bn in net worth and own an island in Hawaii), there is no deal - literally no deal, this is pure nepo - THE OLIGARCHYMiddle Eastern sovereign funds - I mean, they're involved in EVERY major deal of a conservative figure (Musk/Twitter, Musk/Grok, Ellison/Paramount, Ellison/TikTok, Trump/Air Force One) and are backing another consolidation. Is this the greatest capitalist manipulation ever? Dictator capitalism?Robby Starbuck - he claimed “victory” in the Skydance acquisition terms for killing DEI at Paramount, used the opportunity to lick the boot of Brendan Carr, who is almost guaranteed to investigate Netflix given their wokeness. Somehow it's all Robby Starbuck's fault, right?WBD chair Sam Di Piazza - a near lifer at PwC as an accountant until he want to Citi as an i-banker for a stint, served on AT&T's board… an ACCOUNTANT is running the show! No one has heard of him, he's not in any of the news, but ostensibly he (and the board) approved the Netflix deal after dealing with Baby Ellison. The board is the only group that gets all the bids, compares them, and ultimately decides what to agree on and send to shareholders. If they chose Baby Ellison to avoid him throwing a temper tantrum to daddy, there's no hostile takeover and conservatives can rejoice in owning all of media, right? Snap appoints Arlo CEO Matthew McRae to board of directorsPrior to his current role as CEO of Arlo Technologies, which he has held since August 2018, McRae served as Senior Vice President of Strategy at NETGEAR and as Chief Technology Officer at VIZIO for over seven yearsWHO DO YOU BLAME?Evan Spiegel - he owns 53.1% of voting power - there is no one else to blameRobert Murphy - he owns 46.4% of voting power - what if he doesn't like Matt McRae? Do they resort to a thumb war? Who are we kidding, it's still Evan Spiegel's faultInvestors, who, for whatever reason, have OK'ed the idea of dual class shares such that Spiegel and Murphy own 99.5% of the voting power and less than 8% of the economic interest - while Fidelity owns 14.6% of the shares that control 0% of the overall vote. It was banned from index inclusion because the shares had NO voting rights - but somehow Meta is ALLOWED on every index because you have voting rights even if you can NEVER EVER WIN as Zuck owns control. What's the fucking difference??Worst CEOs of the Year Evan Spiegel of Snap

Warren Hogg is the Chief Science Officer of Tampa Bay Water and one of the key voices behind the region's modern water supply system. Amelia Brown is the Demand Management Program Manager who leads the effort to help residents and businesses conserve water and plan for long-term demand. Together, they break down how Tampa Bay nearly reached environmental collapse in the 1990s, why groundwater pumping dried out lakes and wetlands, and how desalination, river withdrawals, and a 15 billion gallon reservoir reshaped the region's entire water strategy. They explain the future pressures of explosive growth, the cost of new infrastructure, the importance of Florida-friendly landscaping, and why every gallon saved delays multimillion-dollar projects. This conversation reveals how water actually gets to your tap and what Tampa Bay must do to secure its water supply for the next generation.0:00:00 - Intro0:03:36 - History of Tampa Bay Water0:21:37 - Water Infrastructure0:26:47 - Saving Water and Rebates0:45:01 - Future Planning1:13:18 - Waste Water1:35:14 - Outro

In this episode, Dr. Will Cole sits down with Dr. Ralph Esposito, Chief Science Officer at AG1, to talk about what's really missing from most people's nutrition - and how precision health is changing the future of wellness. They dive into the science behind nutrient deficiencies, the truth about supplement research, and how food, stress, and lifestyle shape bioavailability and long-term health. Dr. Esposito also reveals exclusive research on AG1's new NextGen and AGZ formulas, the problem with outdated nutrient recommendations, and how AI and metabolomics are redefining functional nutrition. For all links mentioned in this episode, visit www.drwillcole.com/podcast.AG1 has their best offer ever - If you head to DrinkAG1.com/willcole you'll get the welcome kit, a free bottle of Omega 3's, free bottle of Vitamin D3+K2, all 3 AG1 Flavor Sampler and you'll get to try their new sleep supplement AGZ in all 3 flavors for free - which has been a game changer for my nightly routine. That's $126 in free gifts for new AG1 subscribers!Please note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.Sponsors:AG1 has their best offer ever - If you head to DrinkAG1.com/willcole you'll get the welcome kit, a free bottle of Omega 3's, free bottle of Vitamin D3+K2, all 3 AG1 Flavor Sampler and you'll get to try their new sleep supplement AGZ in all 3 flavors for free - which has been a game changer for my nightly routine. That's $126 in free gifts for new AG1 subscribers!Timeline is offering 10% off your order of Mitopure. Go to timeline.com/WILLCOLE.Text ABW to 64000 to get twenty percent off all IQBAR products, plus FREE shipping. Message and data rates may apply.They're running their biggest sale of the year from now to December 2nd. Head to MANUKORA.com/WILLCOLE to get $150 off your first order with their Black Friday Starter Kit, which comes with an MGO 850+ Manuka Honey jar, 35 honey travel sticks, a wooden and a guidebook!The ultimate gift and personal upgrade. Give the gift of glowing health this holiday season. Unlock 20% off FOR LIFE for yourself and every one on your list at Piquelife.com/willcole. If you're ready to finally understand what your gut has been trying to tell you, ask your provider for the Gut Zoomer by Vibrant Wellness — or find a Vibrant-certified provider today at vibrant-wellness.com/willcole.Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today's guest is Dr. Mark Kiel, Chief Science Officer and Founder at Genomenon. Genomenon is a genomics intelligence company that unlocks real-world evidence from biomedical literature to help pharmaceutical and clinical diagnostics companies inform precision medicine, accelerate patient diagnosis, and guide trial design and label expansion. Mark joins Emerj Editorial Director Matthew DeMello to explore how AI can streamline the extraction, organization, and interpretation of genomic and clinical data, enabling faster, more accurate decision-making in pharmaceutical R&D. He also shares practical approaches to integrating AI with human curation, improving workflow efficiency, and scaling insights for rare disease diagnosis, trial design, and drug development strategy. This episode is sponsored by Genomenon. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Dr. Hoffman continues his conversation with clinical pharmacist, author, board-certified clinical nutritionist, and health expert Jim LaValle on the many health benefits of aged garlic extract.

Clinical Pharmacist, Author, Board-Certified Clinical Nutritionist, and Health Expert Jim LaValle details the many health benefits of aged garlic extract, particularly its impact on periodontal disease. He reveals exciting new research findings that show Kyolic Aged Garlic Extract supplements can significantly reduce periodontal pocket depth -- a key indicator of gingivitis and periodontal disease progression. He also highlights the role of aged garlic extract in reducing inflammation and improving gum health, which in turn has significant implications for cardiovascular and cognitive health. The conversation also touches on various formulations of aged garlic extract available from Kyolic, the importance of integrative approaches to health and wellness, and updates on the latest trends in anti-aging medicine, including peptides and GLP-1 agonists.

Pre-Order The Forever Strong PLAYBOOK and receive exclusive bonuses: https://drgabriellelyon.com/playbook/Want ad-free episodes, exclusives and access to community Q&As? Subscribe to Forever Strong Insider: https://foreverstrong.supercast.comIn this fascinating episode, Dr. Gabrielle Lyon talks with neuroscientist Dr. Ben Rein, PhD (author of Why Brains Need Friends), about the science of social connection, emotion, and cognitive health. Dr. Rein, an expert in neurobiology and psychedelic research, reveals the cutting-edge studies that explain why loneliness is as damaging as smoking and how our digital world is affecting our brain's ability to connect.They discuss the neurochemistry of love, the controversial use of MDMA in therapy, and whether AI can ever truly replace human intimacy. This conversation provides an essential look at the biological drivers of happiness, performance, and long-term brain health.Chapter Markers:0:00 - MDMA (Molly): The History & Therapeutic Benefits 5:59 - The Legal Status of MDMA for PTSD 6:44 - The Safety and Effectiveness of MDMA in Clinical Trials 8:29 - PTSD (The Amygdala Alarm) 9:41 - How MDMA Soothes the Amygdala to Access Memory 11:42 - Is There an Alternative to MDMA? (Ketamine's Mechanism) 13:16 - Ketamine and Neuroplasticity for Depression 15:48 - Botox and Empathy: 18:12 - The Problem of Volume: How Screens Depersonalize Interaction 19:48 - The Virtual Disengagement Hypothesis Explained 25:00 - Defining Cognitive and Emotional Empathy 29:43 - MDMA's Link to Serotonin & Social Reward 31:04 - Do SSRIs Have Pro-Social Effects? 36:10 - The Science of Likability and "Easy to Read" Faces 40:10 - Top 3 Ways to Be More Likable49:49 - The Likability Gap: Why You Underestimate How Well-Liked You Are 56:59 - The Neurobiology of Oxytocin, Dopamine, and Serotonin1:09:23 - The Goldilocks Zone of Empathy 1:15:58 - Narcolepsy 1:18:16 - Alcohol: Why the Neurotoxin is Bad for Brain Health 1:21:47 - Exercise and Neurogenesis1:22:27 - Sex, Orgasm, and Oxytocin Release 1:25:06 - Oxytocin During Childbirth Who is Ben Rein:Dr. Ben Rein is an award-winning neuroscientist and Chief Science Officer of the Mind Science Foundation, where he supports early-career researchers in neuroscience. He earned his PhD from SUNY Buffalo and completed postdoctoral training at Stanford University, publishing over 20 peer-reviewed papers on autism, empathy, MDMA, and digital behavior. Recognized by the NIH, the Society for Neuroscience, and Sigma Xi, he also serves as a scientific advisor to more than 20 organizations. With over one million followers and 75 million video views, Dr. Rein is celebrated for making neuroscience accessible to the public and has been featured by outlets such as Good Morning America, ABC News, and PopularMechanics.Thank you to our sponsors:BodyHealth: Use code LYON20 to get 20% off your first order https://www.bodyhealthaffiliates.com/73L4QL3/7XDN2/BON CHARGE Holiday Sale https://boncharge.com for 25% off Pique 20% off for life: https://Piquelife.com/DRLYONFind Ben Rein at: Website: https://www.benrein.com/Instagram: https://www.instagram.com/dr.benrein/#TikTok: https://www.tiktok.com/@dr.benrein?lang=enFacebook:

Satellite Tracking Reveals Increased Global Population Exposure to Floods (2000–2018). Professor Beth Tellman (Chief Science Officer and co-founder of Cloud to Street; Professor at the University of Arizona geography) discusses her peer-reviewed study, published in Nature magazine, using satellite imaging from NASA's Aqua and Terra satellites, equipped with the MODIS optical sensor, to track global flood events. This systematic mapping provides hard data of actual events, augmenting the global flood database, covering 913 observed flood events between 2000 and 2018. Her research identified an increase of up to 24% in the proportion of the population exposed to floods, indicating people are moving faster into flood plains than the general population growth rate. Limitations of the data include satellites being blocked by cloud cover and difficulty tracking sudden events like dam breaks or pluvial events. A significant concern is the underreporting bias of damaging floods in regions like sub-Saharan Africa. 1913 DAYTON

In this episode, we dive deep into the science and controversy surrounding Quantum Upgrade: systems designed to optimize your energy, recovery, and resilience against modern-day stressors like EMFs and 5G. You’ll hear about fascinating studies involving advanced EEG setups, heart rate variability, ATP production, blood health, and even experiments with pets. The guests break down real research, including placebo-controlled trials and randomized studies, investigating everything from wound healing to parasitic load and spike protein traces. They’ll also tackle skepticism head-on, discussing how quantum technology interacts with your biofield, and how you can personalize your own experience with different settings and frequencies. Philipp von Holtzendorff-Fehling, founder and CEO of Leela Quantum Tech and Quantum Upgrade, is a coach, entrepreneur in the conscious-raising space, and energy healer. In parallel to a successful international business career, he constantly worked through blockages and barriers that had prevented him from fully connecting with his true self. With that, he started to also see energy fields and developed his unique skills as a healer, undergoing two decades of training in shamanic and other energy healing modalities. Ian Mitchell founded Wizard Sciences to create a world-class health and wellness research and development company. His professional background as a leader in health and wellness innovation is at the core of Wizard Sciences. As a research scientist and pharmaceutical consultant, Ian Mitchell is Chief Science Officer at Redbud Brands, Chief Science Advisor at Leela Quantum, and Scientific Advisor at Satori Neuro, contributing to the forefront of wellness technology and healthcare entrepreneurship. Ian is also Polymath in Residence at Ecliptic Capital, a hub for fitness and wellness startups.Full Show Notes: https://bengreenfieldlife.com/podcast/qresearch Episode Sponsors: Truvaga: Balance your nervous system naturally with Truvaga's vagus nerve stimulator. Visit Truvaga.com/Greenfieldand use code GREENFIELD30 to save $30 off any Truvaga device. Calm your mind, focus better, and recover faster in just two minutes. CAROL Bike: The science is clear—CAROL Bike is your ticket to a healthier, more vibrant life. And for a limited time, you can get $100 off yours with the code BEN. Don't wait any longer, join over 25,000 riders and visit carolbike.com/ben today. Just Thrive: For a limited time, you can save 20% off a 90 day bottle of Just Thrive Probiotic and Just Calm at justthrivehealth.com/ben with promo code: BEN. That’s like getting a month for FREE! Take control today with Just Thrive! Manukora: You haven’t tasted or seen honey like this before - so indulge and try some honey with superpowers from Manukora. If you head to manukora.com/ben or use code BEN, you’ll automatically get $25 off your Starter Kit. Boundless Bar: If you’re ready to fuel workouts, sharpen your focus, and support whole-body vitality, grab your Boundless Bars now at boundlessbar.com —and save 10% when you sign up for a Boundless Bar subscription.See omnystudio.com/listener for privacy information.